In a finding that could lead to development of new drugs for treating skin cancer, including melanoma, a new study published in the journal Cell Reports reveals that cancerous cells work together to spread further and faster.
Cancer Research UK scientists at The University of Manchester found that some melanoma cells are particularly fast growing, but not very good at invading the surrounding tissue, while other melanoma cells are the opposite - highly invasive but slow-growing.
Basal Cell Cancer of the Skin
Basal cell cancer is a locally invading cancer. It often occurs on the face above a line joining the angle of the mouth and the ear lobe.
Advertisement
In a tumour, the faster growing cells 'piggy-back' along with the more invasive cells, so together they can be more effective in establishing a new tumour once they have reached different parts of the body.
The scientists conducted the research using see-through zebra fish so that they could see how the cancer cells moved and expanded from the original tumour.
![Melanoma]( "Melanoma")
Melanoma of the skin is a dangerous type of skin cancer that usually appears as a cancerous mole due to exposure to the sun's damaging UV rays.
Dr Claudia Wellbrock, study author and Cancer Research UK scientist at The University of Manchester and a member of the Manchester Cancer Research Centre, said: "We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow rapidly. But this research shows that melanoma can spread by 'co-operative invasion'.
"Different types of cancer cells with different strengths and weaknesses are both present in the tumour at the same time and can work together to spread faster and more efficiently. This has profound implications for how we find cures for this terrible disease."
Melanoma is the most dangerous form of skin cancer with around 13,300 people diagnosed in the UK each year.
Worryingly, the incidence rates of malignant melanoma have increased more than fivefold since the mid 1970s.
Professor Richard Marais, director of the Cancer Research UK Manchester Institute, said: "Malignant melanoma is the most deadly form of skin cancer precisely because it spreads quickly and aggressively. This kind of research is vital for establishing how this horrible disease spreads around the body and how we might be able to stop it.
"As well as finding more effective treatments for advanced melanoma, we also need to stress the importance of early diagnosis, detecting tumours before they have a chance to spread."
Source: Eurekalert
Melanoma
Melanoma of the skin is a dangerous type of skin cancer that usually appears as a cancerous mole due to exposure to the sun's damaging UV rays.
Advertisement
Dr Claudia Wellbrock, study author and Cancer Research UK scientist at The University of Manchester and a member of the Manchester Cancer Research Centre, said: "We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow rapidly. But this research shows that melanoma can spread by 'co-operative invasion'.
"Different types of cancer cells with different strengths and weaknesses are both present in the tumour at the same time and can work together to spread faster and more efficiently. This has profound implications for how we find cures for this terrible disease."
Melanoma is the most dangerous form of skin cancer with around 13,300 people diagnosed in the UK each year.
Worryingly, the incidence rates of malignant melanoma have increased more than fivefold since the mid 1970s.
Professor Richard Marais, director of the Cancer Research UK Manchester Institute, said: "Malignant melanoma is the most deadly form of skin cancer precisely because it spreads quickly and aggressively. This kind of research is vital for establishing how this horrible disease spreads around the body and how we might be able to stop it.
"As well as finding more effective treatments for advanced melanoma, we also need to stress the importance of early diagnosis, detecting tumours before they have a chance to spread."
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
